Handbook of Therapeutic Antibodies; Contents; Quick Reference List of Antibodies by International Nonproprietary Name; Quick Reference List of Antibodies by Brand Name; A Greeting by the Editors; Foreword to the First Edition; Foreword to the Second Edition; List of Contributors; Abbreviations; Appendix: Marketed Monoclonal Antibodies Compendium; Volume I: Defining the Right Antibody Composition; Chapter 1 Therapeutic Antibodies -- from Past to Future; 1.1 An Exciting Start -- and a Long Trek; 1.2 The Gold Rush; 1.3 Success and Setbacks; 1.4 The Gleaming Horizon; References; Further Reading
متن يادداشت
2.4.5.4 Cytotoxicity Assays2.4.5.5 Screening for Function; 2.4.6 Cloning; 2.4.7 Expansion and Freezing of Hybridoma Clones; 2.5 Purification and Modification of Monoclonal Antibodies; 2.5.1 Mass Culture and Purification of Monoclonal Antibody; 2.5.2 Fragmentation of Monoclonal IgG Antibodies; 2.5.3 Labeling of Monoclonal Antibodies; 2.6 Monoclonal Antibodies for Tumor Therapy; 2.6.1 Leukocyte Differentiation Antigens; 2.6.2 Epithelial Differentiation Antigens; 2.6.3 Mechanisms of Action of Monoclonal Antibodies; 2.6.4 Human Monoclonal Antibodies; 2.7 Outlook; References
متن يادداشت
5.1 Introduction5.2 History of Humanization; 5.3 CDR-Grafting; 5.4 The Design Cycle; 5.4.1 Analysis of the Source (Donor) Sequence; 5.4.1.1 Complementarity-Determining Regions (CDRs); 5.4.1.2 Canonical Residues; 5.4.1.3 Interface Packing Residues; 5.4.1.4 Rare Framework Residues; 5.4.1.5 N- or O-Glycosylation Sites; 5.4.2 Three-Dimensional Computer Modeling of the Antibody Structure; 5.4.3 Choice of Human Framework Sequences; 5.4.3.1 Fixed Frameworks or Best-Fit?; 5.4.3.2 VL/VH Frameworks from the Same or Different Clone?; 5.4.3.3 Human Subgroup Consensus or Expressed Framework?
متن يادداشت
Part I: Selecting and Shaping the Antibody MoleculeChapter 2 Selection Strategies for Monoclonal Antibodies; 2.1 Introduction; 2.2 Historical Remarks; 2.3 Antibody Structure and Function; 2.3.1 Membrane-Bound and Secreted Forms of Antibodies; 2.3.2 Monoclonal Antibodies; 2.4 Production of Monoclonal Antibodies; 2.4.1 Immunization; 2.4.2 Myeloma Cell Lines; 2.4.3 Cell Fusion; 2.4.4 Drug Selection of Hybridomas; 2.4.5 Screening Hybridoma Cultures for Specific Antibody; 2.4.5.1 Enzyme-Linked Immunosorbent Assay (ELISA); 2.4.5.2 Flow Cytometry; 2.4.5.3 Immunohistology and Immunocytology
بدون عنوان
0
بدون عنوان
8
بدون عنوان
8
بدون عنوان
8
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Still the most comprehensive reference source on the development, production and therapeutic application of antibodies, this second edition is thoroughly updated and now has 30% more content. Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study, as well as their potential. Volumes 3 and 4 feature detailed and specific information about each antibody approved for therapeutic purposes, including clinical data. This unique handbook concludes with a compendium of marketed monoc